REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $958,000 | +447.4% | 49,123 | +358.8% | 0.01% | +400.0% |
Q4 2021 | $175,000 | -88.6% | 10,707 | -78.6% | 0.00% | -83.3% |
Q1 2018 | $1,538,000 | +15280.0% | 49,934 | +12670.8% | 0.01% | – |
Q2 2017 | $10,000 | -82.5% | 391 | -77.9% | 0.00% | – |
Q2 2015 | $57,000 | -95.5% | 1,771 | -95.2% | 0.00% | -100.0% |
Q2 2014 | $1,262,000 | +3.9% | 37,118 | -3.8% | 0.01% | 0.0% |
Q1 2014 | $1,215,000 | – | 38,573 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |